Compliance With Once Daily Glaucoma Medication

N/ACompletedNCT00333463

Alcon Research700 enrolled

Overview

A study to examine patient compliance with once daily glaucoma medication

Study Type

OBSERVATIONAL

Enrollment

700

Conditions

Compliance

Interventions

InterventionBEHAVIORAL

The intervention group watched an educational video, reviewed current barriers to drop-taking and possible solutions with a study coordinator, received regular phone call reminders, and had audible and visible reminders activated on their DA devices.

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Primary open angle glaucoma or ocular hypertension patients Exclusion Criteria: * None

Locations (1)

Ft. Worth

Fort Worth, Texas, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.